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Lipid-Rich Versus Fibrous
Intimal Hyperplasia in
Transplant Vasculopathy
In the June 2012 issue of iJACC, Hou et al. (1) reported that the
optical coherence tomography (OCT), compared with intravascular
ultrasound (IVUS), was more sensitive for early detection of cardiac
Figure 1. Diffuse Cardiac Allograft Vasculopathy
Intravascular ultrasound (IVUS) (A), angiography (B), and near-infrared spectrosc
18-year-old male patient 11 years after heart transplantation for dilated cardiom
sectional image. White lines (B and C) represent a region of the angiogram co
received immunosuppressive therapy with lipid-lowering agents (tacrolimus, pr
diffuse disease especially prominent in the mid LAD. Pruning of the secondary
and NIRS chemogram lipid core burden index  0.llograft vasculopathy (CAV). Mean intimal hyperplasia (IH) was
80 m. IH thickness 150 m accounted for 31% of assessable
segments, which is underresolution of IVUS. Lipid-rich plaques
(LCPs) with thin fibrous caps were found by OCT in 43% of
transplant recipients.
The incidence of CAV is as high as 50% at 5 years after
transplantation, and survival is substantially curtailed after the
diagnosis of CAV is established. Despite the significant progress in
the control of cellular rejection, the evolution of graft vasculopathy
has continued unabated. Aggressive control of established risk
factors and some of the newer antiproliferative agents remain the
cornerstone of CAV management. Use of statins has demonstrated
an outcome benefit by cholesterol reduction and also by the
cholesterol-independent immune-modulating effect on the natural
killer cells; the immunomodulatory efficacy of statins is exaggerated
in the presence of a calcineurin inhibitor (2).
We need to use sensitive tools for the diagnosis and screening of
CAV to develop novel treatment strategies. Due to the denervation of
transplanted hearts, symptoms of vasculopathy are usually not obvious.
Therefore, coronary angiography is repeated annually in most trans-
plantation centers. However, information obtained from angiography
is often limited because CAV is diffuse. IVUS is able to accurately
image the 3 vessel wall layers, and the IH evaluation by IVUS
correlates with the occurrence of adverse events post-transplantation.
IH of500m in the first year after transplantation predicts increased
ortality, myocardial infarction, and late development of severe CAV
nd heart failure (3). Further differentiation of fibrous from lipid-rich
eointima offers a significant prognostic and therapeutic advantage.
lthough gray-scale IVUS is unable to determine the etiology of
AV, intravascular OCT generates cross-sectional vessel images with
0-fold higher resolution than IVUS and with a more precise charac-
erization of IH. Assessment of lipid-rich lesions is also possible by
ear-infrared spectroscopy (NIRS), in which the NIRS measurements
re presented as a chemogram with the probability of a lipid core
ontaining plaques on a color scale from red to yellow (0 for red, 1 for
(NIRS) (C) scans of the medial left anterior descending artery (LAD) in an
athy. The white arrow (B) indicates the location of the presented IVUS cross-
onding to the NIRS scan. Yellow lines (C) represent 2-mm blocks. The patient
sone, mycophenolate, aspirin, and simvastatin). Coronary angiography showed
tertiary coronary vasculature is evident. IVUS minimal lumen area  4.5 cm2,opy
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Letters to the Editor 127yellow). Chemogram analysis enables one to divide the scan into 2-mm
blocks and quantify the amount of lipid on a scale of 0 to 1,000, termed
the lipid core burden index (LCBI).
Similar toHou et al., we captured 2 distinct patterns of CAV byNIRS
during the routine hemodynamic and angiographic assessment in long-
term survivors after heart transplantation. Simultaneous gray-scale IVUS
and NIRS scans in the 2 allograft recipients 11 and 19 years after the
transplantation demonstrated fibrotic (Fig. 1) and lipid-rich plaques
(Fig. 2), respectively. Interestingly, the NIRS chemogram showed lipid-
rich regions, even for the angiographically normal-appearing vessel in the
latter patient who did not receive statin therapy.
The 2 different NIRS scans of CAV in transplant recipients may
correspond to the difference in elapsed survival time from trans-
plantation and use of medical therapy. Autopsy studies have
confirmed that in the first 5 years after transplantation, CAV
plaques are mostly composed of fibrotic tissue, whereas lipid
accumulation is seen later. Gray-scale IVUS studies have provided
some insight into the etiology of CAV in survivors 1 to 9 years
post-transplantation (4). They have revealed diffuse and circumferen-
tial lesions in mid and distal coronary segments, suggestive of the
fibrotic tissue. Focal and noncircumferential lesions observed in the
proximal segment of the vessel early after transplantation indicated
pre-existing atherosclerotic lesions. Radiofrequency (RF) analysis by
IVUS (virtual histology) suggested that lipid-rich regions in neointima
increased and fibrosis decreased with time over 1 to 20 years after the
heart transplantation (5). However, the accuracy of RF-IVUS in
lipid-rich plaque determination has been questioned, and character-
ization of the IH by other imaging modalities should be confirmatory.
Interestingly, the accelerated lipid-rich atherosclerotic process in CAV
seems to be slower compared with vein coronary graft plaques and
in-stent restenosis development. This insidious process is often a result
of younger vasculature of the allografts, which is likely to be devoid of
pre-existing disease. The immunosuppressive therapy could also con-
tribute to the delay in the process; statin supplementation further
enhances the immunosuppressive efficacy of calcineurin inhibitors.
New intravascular imaging modalities may improve CAV
Figure 2. Lipid-Rich Cardiac Allograft Vasculopathy
IVUS (A), angiography (B), and NIRS (C) scans of the medial right coronary arte
of the presented IVUS cross-sectional image. White lines (B and C) represent a
sent 2-mm blocks. The patient underwent heart transplantation 19 years earlier
severe left ventricular dysfunction. His medical regimen (tacrolimus, sirolimus, n
nary angiography revealed a focal 80% lesion in the mid RCA, IVUS minimal lum
(blue lines). Abbreviations as in Figure 1.screening in allograft recipients. They would contribute to thenderstanding of the disease process and help to better define
anagement strategies. Allograft vasculopathy is not unique to
eart transplantation and may occur similarly in all transplanted
rgans, and the knowledge gained from coronary screening may
ave wider implications.
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Prognostic Value of
Coronary CT Angiography
We read with interest the paper from Andreini et al. (1) that provided
more evidence on the prognostic value of cardiac computed tomography
CA) in a 24-year-old male patient. The white arrow (B) indicates the location
ion of the angiogram corresponding to the NIRS scan. Yellow lines (C) repre-
r aortic root wrapping surgery for an aortic root aneurysm that resulted in
ipine, losartan, and aspirin) did not include any lipid-lowering therapy. Coro-
area  3.5 cm2, and a lipid core burden index in a 4-mm segment  524ry (R
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afte
ifed
enangiography (CTA) in patients referred for evaluation of possible coronary
